홈PTKFF • OTCMKTS
add
Kalbe Farma Tbk PT
시장 뉴스
재무
손익계산서
수익
순이익
(IDR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
수익 | 7.91조 | 7.16% |
운영비 | 2.29조 | 15.55% |
순이익 | 5732.83억 | 6.97% |
순이익률 | 7.25 | -0.14% |
주당 수익 | 12.41 | 7.73% |
EBITDA | 8748.12억 | 1.14% |
유효 세율 | 23.01% | — |
대차대조표
총자산
총부채
(IDR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 4.32조 | 45.45% |
총자산 | 28.75조 | 5.78% |
총부채 | 4.84조 | 0.67% |
총자기자본 | 23.91조 | — |
발행 주식 | 461.49억 | — |
주가순자산비율 | 0.00 | — |
총자산이익률 | 6.15% | — |
자본이익률 | 7.16% | — |
현금 흐름
순현금흐름
(IDR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
순이익 | 5732.83억 | 6.97% |
영업 현금 흐름 | 1.16조 | 22.56% |
투자 현금 흐름 | -1766.41억 | 33.78% |
자금 조달 현금 흐름 | -4211.08억 | 51.91% |
순현금흐름 | 4818.57억 | 1,978.42% |
잉여 현금 흐름 | 7520.02억 | 13.84% |
정보
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
설립
1966. 9. 10.
웹사이트
직원 수
12,924